Table 2 Clinical information of the two groups
Clinical information | MPNP group (n = 11) | N-MPNP group (n = 20) | P value |
|---|---|---|---|
Hospitalization days | 18.0 (10.0–22.0) | 23.5 (13.5–47.0) | 0.055a |
Fever duration | 13.0 (10.0–15.0) | 11.5 (7.3–30.0) | 0.868b |
Clinical presentation (n,%) | |||
Chest pain | 4 (36.36%) | 9 (45%) | 0.718 |
Dyspnea | 5 (45.45%) | 14 (70%) | 0.255 |
Wheezing | 2 (18.18%) | 6(30%) | 0.676 |
Digestive symptoms | 6 (54.55%) | 8(40%) | 0.477 |
Feeding difficulty | 5 (45.45%) | 9 (45%) | 1 |
Signs | |||
Shortness of breath | 2 (10%) | 14 (70%) | 0.02 |
Cyanosis | 3 (27.27%) | 6(30%) | 1 |
Lowered breath sound | 6 (54.55%) | 10 (50%) | 0.555 |
Moist rales | 5 (45.45%) | 8 (40%) | |
Dry rales | 0 | 2 (10%) | |
Extrapulmonary complications (n,%) | |||
Digestive system | 4 (36.36%) | 6 (30%) | 1 |
Cardiovascular system | 3 (27.27%) | 3 (15%) | 0.638 |
Nervous system | 0 | 1 (5%) | 1 |
Blood system | 1 (9.09%) | 1 (5%) | 1 |
Rash and joint muscle system | 2 (18.18%) | 1 (5%) | 0.281 |
Two systems | 0 | 3 (15%) | 0.535 |
Three systems and more | 3 (27.27%) | 1 (5%) | 0.115 |